| 2024 |
Inflammation scores based on C-reactive protein and albumin predict mortality in hospitalized older patients independent of the admission diagnosis |
Articolo in rivista |
Vai |
| 2024 |
Corrigendum to “CAR, mGPS and hs-mGPS: Which of these is the best gero-biomarker for age-related diseases? And for what clinical application?” [Mech. Aging Dev. 220 (2024) 111952] |
Nota o commento |
Vai |
| 2024 |
miRNA-Driven Regulation of Endothelial-to-Mesenchymal Transition Differs among Thoracic Aortic Aneurysms |
Articolo in rivista |
Vai |
| 2024 |
CAR, mGPS and hs-mGPS: What is among them the best gero-biomarker for age-related diseases? And for what clinical application? |
Articolo in rivista |
Vai |
| 2024 |
Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets |
Review essay (rassegna critica) |
Vai |
| 2023 |
Could the Combination of eGFR and mGPS Facilitate the Differential Diagnosis of Age-Related Renal Decline from Diseases? A Large Study on the Population of Western Sicily |
Articolo in rivista |
Vai |
| 2023 |
A promising therapeutic peptide and preventive/diagnostic biomarker for age-related diseases: The Elabela/Apela/Toddler peptide |
Review essay (rassegna critica) |
Vai |
